Does down-regulation of HDGF inhibit the Growth of Hepatocellular Carcinoma Cells In Vitro and In Vivo?
These findings suggest that targeted inhibition of HDGF may be a novel anti-HCC therapy.
Of the true pathology identified, over half were not evident on clinical presentation, emphasizing the importance of a routine surveillance. However, an image intense surveillance program has a high rate of initially indeterminate findings. J. Surg. Oncol. 2016;113:818-822. © 2016 Wiley Periodicals, Inc.